Evolus, Inc.

Evolus, Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Newport Beach, CA, United States • EOLS (NGM)

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

949 284 4555 520 Newport Center Drive, Newport Beach, CA 92660, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Orange County Business Journal • Dec 28
Evolus, Inc. $EOLS Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
MarketBeat • Dec 27
Needham Reiterates Evolus (EOLS) Hold Recommendation - Nasdaq
Nasdaq • Dec 24
Needham Reiterates Hold Rating for Evolus (EOLS) | EOLS Stock Ne - GuruFocus
GuruFocus • Dec 24
Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS) - Seeking Alpha
Seeking Alpha • Dec 17

Other Drug Manufacturers - Specialty & Generic Companies

View All →
Elanco Animal Health Inc logo Elanco Animal Health Inc.
1 layoff tracked
$11.23B market cap
Zoetis Inc. logo Zoetis Inc.
$55.83B market cap
Galderma Group AG/ADR logo Galderma Group AG
$49.28B market cap
TAKEDA PHARMACEUTICAL CO LTD logo Takeda Pharmaceutical Co. Ltd.
$47.02B market cap
Haleon plc logo Haleon PLC
$44.93B market cap
TEVA PHARMACEUTICAL INDUSTRIES LTD logo TEVA Pharmaceutical Industries Ltd.
$32.82B market cap

Frequently Asked Questions

Has Evolus, Inc. had layoffs?
No layoff events have been recorded for Evolus, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Evolus, Inc. have?
Evolus, Inc. has approximately 329 employees.
What industry is Evolus, Inc. in?
Evolus, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Evolus, Inc. a publicly traded company?
Yes, Evolus, Inc. is publicly traded under the ticker symbol EOLS on the NGM. The company has a market capitalization of approximately $0.45 billion.
Where is Evolus, Inc. headquartered?
Evolus, Inc. is headquartered in Newport Beach, CA, United States at 520 Newport Center Drive, Newport Beach, CA 92660, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.